Israel is home to world-renowned ulcerative colitis centers recognized for multidisciplinary care and pioneering research. Top facilities include Tel Aviv Sourasky Medical Center (Ichilov), Hadassah Medical Center, and Sheba Medical Center. These JCI-accredited institutions utilize advanced diagnostics, including genetic and microbial analysis, to personalize inflammatory bowel disease (IBD) treatment plans.
- Sourasky (Ichilov): Specializes in bacteriotherapy and personalized immunology led by Prof. Maharshak Nitzan.
- Hadassah Medical Center: Recognized for managing complex pediatric cases and advanced biological therapies.
- Sheba Medical Center: Ranked globally by Newsweek for research-driven interventions and specialized clinical trials.
- Assuta Medical Center: Offers the largest private surgical facility with faster access to senior experts.
- Rambam Medical Center: Manages 70+ clinical trials focused on microbiome investigation and novel drugs.
Bookimed Expert Insight: Patient volume serves as a critical quality indicator in Israel. Our data shows Hadassah and Sourasky serve 1,000,000 and 1,800,000 patients yearly, respectively. This high volume allows surgeons like Dr. Ron Greenberg to specialize intensely in colorectal procedures. Centers with these scales often provide specialized pediatric tracks, such as those led by Dr. Bentov Amir.
Patient Consensus: Patients note that while public centers offer top research-driven results, private options like Assuta are better for skipping long administrative queues. Many highlight the success of switching to biologics like Vedolizumab at major Jerusalem units after previous treatment failures.